Clinical Trial

Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study

Study acronym: DIFTOB
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 7, 2022 (before its estimated June 2024 completion). Its status may not reflect the trial's current state.
Summary
There are several studies performed to reveal the linkage between diet, fecal microbiota, and obesity. Human fecal microbiota transplantations in this asset are still scarce. Therefore, this pilot study of FMT from lean to obese people with dietary counseling will increase the knowledge, whether FMT could play a role in the treatment of obesity and NAFLD. Our primary outcome is the changes in glucose metabolism by HOMA-IR.
Trial Details
NCT Number NCT05607745
Lead Sponsor University of Eastern Finland
Collaborators: Helsinki University Central Hospital, Päijänne Tavastia Central Hospital, University of Helsinki, Kuopio University Hospital, Kuopio Research Institute of Exercise Medicine
Conditions NAFLD, Fecal Microbiota, Gut Microbiota, Obesity, Dietary Habits, Diet, Fecal Microbiota Transplantation, Glucose Metabolism Disorders +1 more
Enrollment 54 participants
Start Date 2022-10-30
Primary Completion 2024-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2022-11-07